Poll

Poll: How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?

Let us know how familiar are you on the approval process for biosimilar drugs compared with new drug applications to the FDA. The poll will be open until February 28, 2023.

How familiar are you on the approval process for biosimilar drugs in comparison to new drug applications to the FDA?

Very familiar
Familiar
Slightly or somewhat familiar
Not familiar
Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
© 2024 MJH Life Sciences

All rights reserved.